Literature DB >> 23389690

Inactivation of JAK2/STAT3 signaling axis and downregulation of M1 mAChR cause cognitive impairment in klotho mutant mice, a genetic model of aging.

Seok-Joo Park1, Eun-Joo Shin, Sun Seek Min, Jihua An, Zhengyi Li, Yoon Hee Chung, Ji Hoon Jeong, Jae-Hyung Bach, Seung-Yeol Nah, Won-Ki Kim, Choon-Gon Jang, Yong-Sun Kim, Yo-Ichi Nabeshima, Toshitaka Nabeshima, Hyoung-Chun Kim.   

Abstract

We previously reported cognitive dysfunction in klotho mutant mice. In the present study, we further examined novel mechanisms involved in cognitive impairment in these mice. Significantly decreased janus kinase 2 (JAK2) and signal transducer and activator of transcription3 (STAT3) phosphorylation were observed in the hippocampus of klotho mutant mice. A selective decrease in protein expression and binding density of the M1 muscarinic cholinergic receptor (M1 mAChR) was observed in these mice. Cholinergic parameters (ie, acetylcholine (ACh), choline acetyltransferase (ChAT), and acetylcholinesterase (AChE)) and NMDAR-dependent long-term potentiation (LTP) were significantly impaired in klotho mutant mice. McN-A-343 (McN), an M1 mAChR agonist, significantly attenuated these impairments. AG490 (AG), a JAK2 inhibitor, counteracted the attenuating effects of McN, although AG did not significantly alter the McN-induced effect on AChE. Furthermore, AG significantly inhibited the attenuating effects of McN on decreased NMDAR-dependent LTP, protein kinase C βII, p-ERK, p-CREB, BDNF, and p-JAK2/p-STAT3-expression in klotho mutant mice. In addition, k252a, a BDNF receptor tyrosine kinase B (TrkB) inhibitor, significantly counteracted McN effects on decreased ChAT, ACh, and M1 mAChR and p-JAK2/p-STAT3 expression. McN-induced effects on cognitive impairment in klotho mutant mice were consistently counteracted by either AG or k252a. Our results suggest that inactivation of the JAK2/STAT3 signaling axis and M1 mAChR downregulation play a critical role in cognitive impairment observed in klotho mutant mice.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23389690      PMCID: PMC3682136          DOI: 10.1038/npp.2013.39

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  45 in total

1.  Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice.

Authors:  Stephan G Anagnostaras; Geoffrey G Murphy; Susan E Hamilton; Scott L Mitchell; Nancy P Rahnama; Neil M Nathanson; Alcino J Silva
Journal:  Nat Neurosci       Date:  2003-01       Impact factor: 24.884

2.  Spectrophotometric assay for choline acetyltransferase.

Authors:  L P Chao; F Wolfgram
Journal:  Anal Biochem       Date:  1972-03       Impact factor: 3.365

3.  Rapid response of striatal muscarinic M1-receptor mRNA to muscarinic cholinergic agents in rat brain.

Authors:  H Chou; N Ogawa; M Asanuma; H Hirata; Y Kondo; A Mori
Journal:  Brain Res Mol Brain Res       Date:  1993-08

Review 4.  Partial agonists, full agonists, antagonists: dilemmas of definition.

Authors:  D Hoyer; H W Boddeke
Journal:  Trends Pharmacol Sci       Date:  1993-07       Impact factor: 14.819

5.  Phosphatidylinositol 3-kinase: a molecule mediating BDNF-dependent spatial memory formation.

Authors:  M Mizuno; K Yamada; N Takei; M H Tran; J He; A Nakajima; H Nawa; T Nabeshima
Journal:  Mol Psychiatry       Date:  2003-02       Impact factor: 15.992

6.  Human amnesia and the medial temporal region: enduring memory impairment following a bilateral lesion limited to field CA1 of the hippocampus.

Authors:  S Zola-Morgan; L R Squire; D G Amaral
Journal:  J Neurosci       Date:  1986-10       Impact factor: 6.167

7.  Effect of subchronic galantamine treatment on neuronal nicotinic and muscarinic receptor subtypes in transgenic mice overexpressing human acetylcholinesterase.

Authors:  Marie M Svedberg; Ivan Bednar; Agneta Nordberg
Journal:  Neuropharmacology       Date:  2004-09       Impact factor: 5.250

8.  Discrete activation of transduction pathways associated with acetylcholine m1 receptor by several muscarinic ligands.

Authors:  D Gurwitz; R Haring; E Heldman; C M Fraser; D Manor; A Fisher
Journal:  Eur J Pharmacol       Date:  1994-03-15       Impact factor: 4.432

9.  The Jak/STAT pathway is involved in synaptic plasticity.

Authors:  Céline S Nicolas; Stéphane Peineau; Mascia Amici; Zsolt Csaba; Assia Fafouri; Charlotte Javalet; Valerie J Collett; Lars Hildebrandt; Gillian Seaton; Sun-Lim Choi; Su-Eon Sim; Clarrisa Bradley; Kyungmin Lee; Min Zhuo; Bong-Kiun Kaang; Pierre Gressens; Pascal Dournaud; Stephen M Fitzjohn; Zuner A Bortolotto; Kwangwook Cho; Graham L Collingridge
Journal:  Neuron       Date:  2012-01-26       Impact factor: 17.173

Review 10.  M1 muscarinic agonists can modulate some of the hallmarks in Alzheimer's disease: implications in future therapy.

Authors:  Abraham Fisher; Zipora Pittel; Rachel Haring; Nira Bar-Ner; Michal Kliger-Spatz; Niva Natan; Inbal Egozi; Hagar Sonego; Itzhak Marcovitch; Rachel Brandeis
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 2.866

View more
  21 in total

1.  Expression of klotho mRNA and protein in rat brain parenchyma from early postnatal development into adulthood.

Authors:  Sarah M Clinton; Matthew E Glover; Astha Maltare; Ann M Laszczyk; Stephen J Mehi; Rebecca K Simmons; Gwendalyn D King
Journal:  Brain Res       Date:  2013-07-06       Impact factor: 3.252

2.  Klotho regulates CA1 hippocampal synaptic plasticity.

Authors:  Qin Li; Hai T Vo; Jing Wang; Stephanie Fox-Quick; Lynn E Dobrunz; Gwendalyn D King
Journal:  Neuroscience       Date:  2017-02-12       Impact factor: 3.590

3.  Stimulation of ACE2/ANG(1-7)/Mas Axis by Diminazene Ameliorates Alzheimer's Disease in the D-Galactose-Ovariectomized Rat Model: Role of PI3K/Akt Pathway.

Authors:  Ahmed S Kamel; Noha F Abdelkader; Sahar S Abd El-Rahman; Marwan Emara; Hala F Zaki; Mahmoud M Khattab
Journal:  Mol Neurobiol       Date:  2018-03-07       Impact factor: 5.590

4.  Neuroprotective Effect of Nanodiamond in Alzheimer's Disease Rat Model: a Pivotal Role for Modulating NF-κB and STAT3 Signaling.

Authors:  Shawqi H Alawdi; Ezzeldin S El-Denshary; Marwa M Safar; Housam Eidi; Marie-Odile David; Mosaad A Abdel-Wahhab
Journal:  Mol Neurobiol       Date:  2016-02-20       Impact factor: 5.590

5.  Tacrolimus Decreases Cognitive Function by Impairing Hippocampal Synaptic Balance: a Possible Role of Klotho.

Authors:  Yoo Jin Shin; Sun Woo Lim; Sheng Cui; Eun Jeong Ko; Byung Ha Chung; Hong Lim Kim; Tae Ryong Riew; Mun Yong Lee; Chul Woo Yang
Journal:  Mol Neurobiol       Date:  2021-08-25       Impact factor: 5.590

6.  JAK2/STAT3 Signaling Pathway and Klotho Gene in Cadmium-induced Neurotoxicity In Vitro and In Vivo.

Authors:  Shuzhen Liu; Dongmei Yu; Peng Wei; Jiansheng Cai; Min Xu; Haoyu He; Xu Tang; Chuntao Nong; Yi Wei; Xia Xu; Xiaoting Mo; Zhiyong Zhang; Jian Qin
Journal:  Biol Trace Elem Res       Date:  2022-09-27       Impact factor: 4.081

7.  A novel role for brain interleukin-6: facilitation of cognitive flexibility in rat orbitofrontal cortex.

Authors:  Jennifer J Donegan; Milena Girotti; Marc S Weinberg; David A Morilak
Journal:  J Neurosci       Date:  2014-01-15       Impact factor: 6.167

8.  The age-regulating protein klotho is vital to sustain retinal function.

Authors:  Nicholas J Reish; Astha Maltare; Alex S McKeown; Ann M Laszczyk; Timothy W Kraft; Alecia K Gross; Gwendalyn D King
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-10-11       Impact factor: 4.799

9.  Altered KLOTHO and NF-κB-TNF-α Signaling Are Correlated with Nephrectomy-Induced Cognitive Impairment in Rats.

Authors:  Sabrina Degaspari; Carmen Branco Tzanno-Martins; Clarice Kazue Fujihara; Roberto Zatz; João Paulo Branco-Martins; Tania Araujo Viel; Hudson de Souza Buck; Ana Maria Marques Orellana; Ana Elisa Böhmer; Larissa de Sá Lima; Diana Zukas Andreotti; Carolina Demarchi Munhoz; Cristoforo Scavone; Elisa Mitiko Kawamoto
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

10.  Melatonin attenuates memory impairment induced by Klotho gene deficiency via interactive signaling between MT2 receptor, ERK, and Nrf2-related antioxidant potential.

Authors:  Eun-Joo Shin; Yoon Hee Chung; Hoang-Lan Thi Le; Ji Hoon Jeong; Duy-Khanh Dang; Yunsung Nam; Myung Bok Wie; Seung-Yeol Nah; Yo-Ichi Nabeshima; Toshitaka Nabeshima; Hyoung-Chun Kim
Journal:  Int J Neuropsychopharmacol       Date:  2014-12-30       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.